Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,206.00
+6.50 (0.54%)
Nov 12, 2026, 3:29 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.2 trillion as of November 12, 2026. It is the 1,780th most valuable company in the world and the 92nd biggest in India. Its market cap has increased by 27.33% in one year.
Market Cap
1.20T
Enterprise Value
1.32T
Revenue
303.78B
Global Rank
Country Rank
#92 India
PE Ratio
28.83
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.20T, an increase of 14,578.15%. That is a compound annual growth rate of 22.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.20T | 30.75% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 3.02T |
| Laurus Labs | 1.31T |
| Cipla | 1.15T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.05T |
| Glenmark Pharmaceuticals | 755.56B |
| Alkem Laboratories | 651.39B |
| Gland Pharma | 537.79B |